|
| View:
Latest News | Top Stories |
|
| Sunday, Dec 6, 2009 |
|
| · | [external] Better Biotech Buy: Celgene or Genzyme? at Motley Fool -
Sun 12:11 am ET |
|
| Saturday, Dec 5, 2009 |
|
| · | Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting GlobeNewswire -
Sat 10:00 am ET |
|
| Friday, Dec 4, 2009 |
|
| · | [external] Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 1) at TheStreet.com -
Fri 6:39 pm ET |
|
| · | The Coming Week's Game Plan: Blood, Tech and Jeers at CNBC -
Fri 6:21 pm ET |
|
| · | [external] NASDAQ warns Discovery Laboratories on stock price at bizjournals.com -
Fri 6:05 pm ET |
|
| · | Pulmo BioTech Inc. Announces Further Details of the Background to Its Previously Announced Letter of Intent Regarding the Proposed License of Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the Polish Company, Biotechno Marketwire -
Fri 5:36 pm ET |
|
| · | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Hemispherx Biopharma, Inc. (AMEX: HEB) Marketwire -
Fri 4:27 pm ET |
|
| · | Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price GlobeNewswire -
Fri 4:15 pm ET |
|
| · | Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference PR Newswire -
Fri 4:00 pm ET |
|
| · | [external] Our Final Offer (Maybe)! That's a FACT! at Motley Fool -
Fri 3:29 pm ET |
|
| · | Significant Deal for AZN Zacks.com -
Fri 3:02 pm ET |
|
| · | Ziopharm Oncology to raise $45.2M in public offer AP -
Fri 2:23 pm ET |
|
| · | BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange Business Wire -
Fri 2:01 pm ET |
|
| · | PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop PR Newswire -
Fri 1:30 pm ET |
|
| · | Celgene's ASH Monday at CNBC -
Fri 11:20 am ET |
|
| · | PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop PR Newswire -
Fri 11:01 am ET |
|
| · | ZIOPHARM Prices Public Offering Business Wire -
Fri 9:31 am ET |
|
| · | [external] Hemispherx Needs to Face Reality at TheStreet.com -
Fri 9:30 am ET |
|
| · | [external] Hemispherx Upbeat Despite FDA setback at TheStreet.com -
Fri 9:30 am ET |
|
| · | Skymark Research Initiates Independent Research Coverage on Protalix Biotherapeutics, Inc. GlobeNewswire -
Fri 9:00 am ET |
|
|
More Latest News...
|